Literature DB >> 29661809

The Multiple Roles of B Cells in Multiple Sclerosis and Their Implications in Multiple Sclerosis Therapies.

Rui Li1, Amit Bar-Or1.   

Abstract

Increasing evidence has suggested that both antibody-dependent and antibody-independent functions of B cells are involved in multiple sclerosis (MS). The contrasting results of distinct B-cell targeting therapies in MS patients underscores the importance of elucidating these multiple B-cell functions. In this review, we discuss the generation of autoreactive B cells, migration of B cells into the central nervous system (CNS), and how different functions of B cells may contribute to MS disease activity and potentially mitigation in both the periphery and CNS compartments. In addition, we propose several future therapeutic strategies that may better target/shape B-cell responses for long-term treatment of MS.
Copyright © 2019 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 29661809      PMCID: PMC6444698          DOI: 10.1101/cshperspect.a029108

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  173 in total

1.  B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity.

Authors:  Martin S Weber; Thomas Prod'homme; Juan C Patarroyo; Nicolas Molnarfi; Tara Karnezis; Klaus Lehmann-Horn; Dimitry M Danilenko; Jeffrey Eastham-Anderson; Anthony J Slavin; Christopher Linington; Claude C A Bernard; Flavius Martin; Scott S Zamvil
Journal:  Ann Neurol       Date:  2010-09       Impact factor: 10.422

2.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors:  Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

Review 3.  B cells as antigen presenting cells.

Authors:  Daniel Rodríguez-Pinto
Journal:  Cell Immunol       Date:  2006-03-30       Impact factor: 4.868

Review 4.  Antibody-independent functions of B cells: a focus on cytokines.

Authors:  Ping Shen; Simon Fillatreau
Journal:  Nat Rev Immunol       Date:  2015-06-12       Impact factor: 53.106

5.  The role of IL-15 in activating STAT5 and fine-tuning IL-17A production in CD4 T lymphocytes.

Authors:  Pushpa Pandiyan; Xiang-Ping Yang; Senthil S Saravanamuthu; Lixin Zheng; Satoru Ishihara; John J O'Shea; Michael J Lenardo
Journal:  J Immunol       Date:  2012-09-19       Impact factor: 5.422

6.  Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.

Authors:  J W Peterson; L Bö; S Mörk; A Chang; B D Trapp
Journal:  Ann Neurol       Date:  2001-09       Impact factor: 10.422

Review 7.  The regulation of IL-10 production by immune cells.

Authors:  Margarida Saraiva; Anne O'Garra
Journal:  Nat Rev Immunol       Date:  2010-02-15       Impact factor: 53.106

8.  Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial.

Authors:  Amit Bar-Or; Peter A J Calabresi; Douglas Arnold; Douglas Arnlod; Clyde Markowitz; Stuart Shafer; Lloyd H Kasper; Emmanuelle Waubant; Suzanne Gazda; Robert J Fox; Michael Panzara; Neena Sarkar; Sunil Agarwal; Craig H Smith
Journal:  Ann Neurol       Date:  2008-03       Impact factor: 10.422

9.  IL-17 and GM-CSF expression are antagonistically regulated by human T helper cells.

Authors:  Rebecca Noster; René Riedel; Mir-Farzin Mashreghi; Helena Radbruch; Lutz Harms; Claudia Haftmann; Hyun-Dong Chang; Andreas Radbruch; Christina E Zielinski
Journal:  Sci Transl Med       Date:  2014-06-18       Impact factor: 17.956

10.  Pleural innate response activator B cells protect against pneumonia via a GM-CSF-IgM axis.

Authors:  Georg F Weber; Benjamin G Chousterman; Ingo Hilgendorf; Clinton S Robbins; Igor Theurl; Louisa M S Gerhardt; Yoshiko Iwamoto; Tam D Quach; Muhammad Ali; John W Chen; Thomas L Rothstein; Matthias Nahrendorf; Ralph Weissleder; Filip K Swirski
Journal:  J Exp Med       Date:  2014-05-12       Impact factor: 14.307

View more
  7 in total

Review 1.  The role of B cells in multiple sclerosis: Current and future therapies.

Authors:  Austin Negron; Rachel R Robinson; Olaf Stüve; Thomas G Forsthuber
Journal:  Cell Immunol       Date:  2018-10-21       Impact factor: 4.868

2.  Longitudinally persistent cerebrospinal fluid B cells can resist treatment in multiple sclerosis.

Authors:  Ariele L Greenfield; Ravi Dandekar; Akshaya Ramesh; Erica L Eggers; Hao Wu; Sarah Laurent; William Harkin; Natalie S Pierson; Martin S Weber; Roland G Henry; Antje Bischof; Bruce Ac Cree; Stephen L Hauser; Michael R Wilson; H-Christian von Büdingen
Journal:  JCI Insight       Date:  2019-03-21

3.  CNS-Specific Synthesis of Interleukin 23 Induces a Progressive Cerebellar Ataxia and the Accumulation of Both T and B Cells in the Brain: Characterization of a Novel Transgenic Mouse Model.

Authors:  Louisa Nitsch; Julian Zimmermann; Marius Krauthausen; Markus J Hofer; Raman Saggu; Gabor C Petzold; Michael T Heneka; Daniel R Getts; Albert Becker; Iain L Campbell; Marcus Müller
Journal:  Mol Neurobiol       Date:  2019-06-02       Impact factor: 5.590

4.  Early B cell tolerance defects in neuromyelitis optica favour anti-AQP4 autoantibody production.

Authors:  Elizabeth Cotzomi; Panos Stathopoulos; Casey S Lee; Alanna M Ritchie; John N Soltys; Fabien R Delmotte; Tyler Oe; Joel Sng; Ruoyi Jiang; Anthony K Ma; Jason A Vander Heiden; Steven H Kleinstein; Michael Levy; Jeffrey L Bennett; Eric Meffre; Kevin C O'Connor
Journal:  Brain       Date:  2019-06-01       Impact factor: 13.501

5.  Astrocyte-specific expression of interleukin 23 leads to an aggravated phenotype and enhanced inflammatory response with B cell accumulation in the EAE model.

Authors:  Louisa Nitsch; Simon Petzinna; Julian Zimmermann; Linda Schneider; Marius Krauthausen; Michael T Heneka; Daniel R Getts; Albert Becker; Marcus Müller
Journal:  J Neuroinflammation       Date:  2021-04-27       Impact factor: 8.322

6.  Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology.

Authors:  José I Fernández-Velasco; Enric Monreal; Jens Kuhle; Virginia Meca-Lallana; José Meca-Lallana; Guillermo Izquierdo; Celia Oreja-Guevara; Francisco Gascón-Giménez; Susana Sainz de la Maza; Paulette E Walo-Delgado; Paloma Lapuente-Suanzes; Aleksandra Maceski; Eulalia Rodríguez-Martín; Ernesto Roldán; Noelia Villarrubia; Albert Saiz; Yolanda Blanco; Carolina Diaz-Pérez; Gabriel Valero-López; Judit Diaz-Diaz; Yolanda Aladro; Luis Brieva; Cristina Íñiguez; Inés González-Suárez; Luis A Rodríguez de Antonio; José M García-Domínguez; Julia Sabin; Sara Llufriu; Jaime Masjuan; Lucienne Costa-Frossard; Luisa M Villar
Journal:  Front Immunol       Date:  2022-03-21       Impact factor: 7.561

Review 7.  The CXCL13/CXCR5 Immune Axis in Health and Disease-Implications for Intrathecal B Cell Activities in Neuroinflammation.

Authors:  Christine Harrer; Ferdinand Otto; Richard Friedrich Radlberger; Tobias Moser; Georg Pilz; Peter Wipfler; Andrea Harrer
Journal:  Cells       Date:  2022-08-25       Impact factor: 7.666

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.